Litcius/Paper detail

Cryo-EM structure of P-glycoprotein bound to triple elacridar inhibitor molecules

Norie Hamaguchi‐Suzuki, Naruhiko Adachi, Toshio Moriya, Satoshi Yasuda, Masato Kawasaki, K. Suzuki, Satoshi Ogasawara, Naohiko Anzai, Toshiya Senda, Takeshi Murata

2024Biochemical and Biophysical Research Communications19 citationsDOIOpen Access PDF

Abstract

P-glycoprotein (P-gp) is an ATP-binding cassette transporter known for its roles in expelling xenobiotic compounds from cells and contributing to cellular drug resistance through multidrug efflux. This mechanism is particularly problematic in cancer cells, where it diminishes the therapeutic efficacy of anticancer drugs. P-gp inhibitors, such as elacridar, have been developed to circumvent the decrease in drug efficacy due to P-gp efflux. An earlier study reported the cryo-EM structure of human P-gp-Fab (MRK-16) complex bound by two elacridar molecules, at a resolution of 3.6 Å. In this study, we have obtained a higher resolution (2.5 Å) structure of the P-gp- Fab (UIC2) complex bound by three elacridar molecules. This finding, which exposes a larger space for compound-binding sites than previously acknowledged, has significant implications for the development of more selective inhibitors and enhances our understanding of the compound recognition mechanism of P-gp.

Topics & Concepts

EffluxP-glycoproteinMultiple drug resistanceChemistryDrugTransporterATP-binding cassette transporterPharmacologyBiochemistryStereochemistryBiologyGeneAntibioticsDrug Transport and Resistance MechanismsMetal complexes synthesis and propertiesNanoparticle-Based Drug Delivery
Cryo-EM structure of P-glycoprotein bound to triple elacridar inhibitor molecules | Litcius